Finland· FI-REL-REL45558
Exviera
A dasabuvir product containing dasabuvir sodium monohydrate, registered in Finland by AbbVie Deutschland GmbH&Co.KG. The same ATC class is registered in 4 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Dasabuvir is registered in 4 of 19 countries.
Countries holding a registration under ATC J05AP09 (dasabuvir), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 2 of them publish a price we can compare per daily dose
Dasabuvir · ATC J05AP09
4 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- United Kingdom
The record
At a glance
Fimea (Finland)- Active substance
- Dasabuvir sodium monohydrate
- Manufacturer
- AbbVie Deutschland GmbH&Co.KG
- Country
- Finland (FI)
- ATC code
- J05AP09
- ATC class
- Dasabuvir
- Defined daily dose
- 0.5 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1 interaction on record for dasabuvir.
Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dasabuvir · interactions on record
1 record
- 1 moderate
Most severe, free to view
- AbirateroneL02BX03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dasabuvir in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e5d1d6f4-693b-4403-86bd-578fe06aff4b GET /v1/drugs/e5d1d6f4-693b-4403-86bd-578fe06aff4b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.5",
"form": "tabletti, kalvopäällysteinen",
"route": "Suun kautta",
"ddd_unit": "g",
"strength": "250 mg",
"atc_label": "dasabuviiri",
"ma_number": null,
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": "EU/1/14/983/001",
"fimea_rel_id": "REL45558",
"authorised_at": "2015-01-15"
}See everything about dasabuvir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.